FR Alert – Covering:07/25/2019

Todays Federal Register

DEPARTMENT OF COMMERCE

Agency Notice
[Notices] [Page 35854] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2019-15822] ———————————————————————– DEPARTMENT OF COMMERCE International Trade Administration [C-570-081] Glycine From the People’s Republic of China: Notice of Correction to Final Affirmative Countervailing Duty Determination and Countervailing Duty Order AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. FOR FURTHER INFORMATION CONTACT: Tyler Weinhold, AD/CVD Operations, Office VI, Enforcement and Compliance, International Trade
[19-15822][Full Article] [PDF]

DEPARTMENT OF DEFENSE

Agency Notice
SUMMARY: The Department of Defense is publishing the unclassified text of an arms sales notification. FOR FURTHER INFORMATION CONTACT: Karma Job at karma.d.job.civ@mail.mil or (703) 697-8976. SUPPLEMENTARY INFORMATION: This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104- 164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives, Transmittal 19-24 with attached Policy Justification and Sensitivity of Technology. Dated: July 22, 2019. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. BILLING CODE 5001-06-P [[Page 35860]] [GRAPHIC] [TIFF OMITTED] TN25JY19.004 BILLING CODE 5001-06-C Transmittal No. 19-24 Notice of Proposed Issuance of Letter of Offer Pursuant to Section 36(b)(1) of the Arms Export Control Act, as amended
[19-15839][Full Article] [PDF]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency Notice
SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by August 26, 2019. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910-0768. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, PRAStaff@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.
[19-15791][Full Article] [PDF]

INTERNATIONAL TRADE COMMISSION

Agency Notice
SUMMARY: Notice is hereby given that the U.S. International Trade Commission has issued a limited exclusion order (“LEO”) against certain products of eleven respondents found in default. The Commission has also issued a cease and desist order (“CDO”) against respondent Basic Medical Supply, LLC. The investigation is terminated. FOR FURTHER INFORMATION CONTACT: Robert Needham, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708-5468. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its internet server (https://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205-1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on June 24, 2016, based on an amended complaint, as suppleme
[19-15801][Full Article] [PDF]
Agency Notice
[Notices] [Page 35884] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2019-15830] ———————————————————————– INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701-TA-626 and 731-TA-1452-1454 (Preliminary)] Certain Collated Steel Staples From China, Korea, and Taiwan; Determinations On the basis of the record \1\ developed in the subject investigations, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports of certain collated steel staples (“CCS staples”) from China, provided for in subheading 8305.20.00 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than
[19-15830][Full Article] [PDF]
Agency Notice
SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined to terminate the above-captioned investigation with a finding of no violation of section 337 of the Tariff Act of 1930. FOR FURTHER INFORMATION CONTACT: Sidney A. Rosenzweig, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202-708-2532. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202-205-2000. General information concerning the Commission may also be obtained by accessing its internet server (https://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on 202-205- 1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on October 11, 2017, based on a complaint filed on September 5, 2017, by Intellectual Ventures II LLC of Be
[19-15784][Full Article] [PDF]
Agency Notice
SUMMARY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (“ID”) (Order No. 18) of the presiding Administrative Law Judge (“ALJ”) granting complainants’ renewed motion for leave to amend the first amended complaint and notice of investigation. FOR FURTHER INFORMATION CONTACT: Michael Liberman, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-3115. Copies of non- confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205-1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on April 10, 2019, based on a complaint filed by Heraeus Medical
[19-15760][Full Article] [PDF]

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

Agency Notice
SUMMARY: The U.S. Trade Representative has to submit a report to Congress regarding the operation of the Caribbean Basin Initiative (CBI) by December 31, 2019. The Trade Policy Staff Committee (TPSC) invites comments concerning the operation of the CBI, including the performance of each beneficiary country, to assist in preparing the report to Congress on the operation of the CBI program. DATES: The TPSC must receive your written comments by August 30, 2019. ADDRESSES: The TPSC strongly prefers electronic submissions made through the Federal Rulemaking Portal: https://www.regulations.gov, using docket number USTR-2019-0007. Follow the instructions for submitting comments in “Requirements for Submissions” below. For alternatives to on-line submissions, please contact Magaly Garcia, Director for Bolivia, Ecuador, and the Caribbean, at magaly.a.garcia@ustr.eop.gov. FOR FURTHER INFORMATION CONTACT: Please contact Magaly Garcia, Director for Bolivia, Ecuador, and the Caribbean, at magaly.a.garcia@ustr.eop.gov, or 202-395-9539. SUPPLEMENTARY INFORMATION: I. Background 
[19-15764][Full Article] [PDF]